Vera Therapeutics, Inc. - COMMON STOCK (VERA)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
64,326,281
Number of holders
1
Total 13F shares, excl. options
13,762
Shares change
0
Total reported value, excl. options
$211,660
Price
$15.38

Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q4 2023

1 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q4 2023.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13,762 shares of 64,326,281 outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include COMMODORE CAPITAL LP (5,450,000 shares), Kynam Capital Management, LP (3,650,339 shares), Sofinnova Investments, Inc. (3,467,156 shares), FMR LLC (2,774,372 shares), BlackRock Inc. (2,754,894 shares), Woodline Partners LP (2,507,140 shares), STATE STREET CORP (2,181,058 shares), Eversept Partners, LP (1,914,830 shares), VANGUARD GROUP INC (1,633,608 shares), and ORBIMED ADVISORS LLC (1,518,115 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.